Artigo de periodico

Drug repurposing in chagas disease: chloroquine potentiates benznidazole activity against Trypanosoma cruzi In vitro and in vivo (2022)

• Authors:
  • Pandey, Ramendra Pati
  • Nascimento, Marilda Savoia
  • Franco, Caio Haddad
  • Bortoluci, Karina
  • Silva, Marcelo Nunes da
  • Zingales, Bianca
  • Gibald, Daniel
  • Barrios, Leda Castaño
  • Vieira, Joseli Lannes
  • Cariste, Leonardo Moro
  • Vasconcelos, Jose Ronnie
  • Moraes, Carolina Borsoi
  • Freitas Junior, Lucio H
  • Kalil Filho, Jorge Elias
  • Alcântara, Laura
  • Cunha Neto, Edecio
• USP affiliated authors: NASCIMENTO, MARILDA SAVOIA - FM ; SILVA, MARCELO NUNES - IQ ; ZINGALES, BIANCA SILVANA - IQ ; KALIL FILHO, JORGE ELIAS - FM ; CUNHA NETO, EDECIO - FM
• Unidades: FM; IQ
• DOI: 10.1128/aac.00284-22
• Subjects: DOENÇA DE CHAGAS; MEDICAMENTO
• Agências de fomento:
  • Financiamento FAPESP
  • Financiamento CNPq
  • Financiamento FAPERJ
• Language: Inglês
• Imprenta:
  • Publisher place: Washington
  • Date published: 2022
• Source:
  • Título: Antimicrobial Agents and Chemotherapy
  • ISSN: 0066-4804
  • Volume/Número/Paginação/Ano: v. 66, n. 11, p. 1-17, art. e0028422, 2022


Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).

Status:

Artigo possui versão em acesso aberto em repositório (Green Open Access)

Versão do Documento:

Versão submetida (Pré-print)

Acessar versão aberta:

• URL de acesso aberto
• PDF de acesso aberto

Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.

---

Download do texto completo

Tipo	Nome	Link
	3106779.pdf	Direct link

How to cite

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

• ABNT

  PANDEY, Ramendra Pati et al. Drug repurposing in chagas disease: chloroquine potentiates benznidazole activity against Trypanosoma cruzi In vitro and in vivo. Antimicrobial Agents and Chemotherapy, v. 66, n. 11, p. 1-17, 2022Tradução . . Disponível em: https://doi.org/10.1128/aac.00284-22. Acesso em: 16 abr. 2026.

• APA

  Pandey, R. P., Nascimento, M. S., Franco, C. H., Bortoluci, K., Silva, M. N. da, Zingales, B., et al. (2022). Drug repurposing in chagas disease: chloroquine potentiates benznidazole activity against Trypanosoma cruzi In vitro and in vivo. Antimicrobial Agents and Chemotherapy, 66( 11), 1-17. doi:10.1128/aac.00284-22

• NLM

  Pandey RP, Nascimento MS, Franco CH, Bortoluci K, Silva MN da, Zingales B, Gibald D, Barrios LC, Vieira JL, Cariste LM, Vasconcelos JR, Moraes CB, Freitas Junior LH, Kalil Filho JE, Alcântara L, Cunha Neto E. Drug repurposing in chagas disease: chloroquine potentiates benznidazole activity against Trypanosoma cruzi In vitro and in vivo [Internet]. Antimicrobial Agents and Chemotherapy. 2022 ; 66( 11): 1-17.[citado 2026 abr. 16 ] Available from: https://doi.org/10.1128/aac.00284-22

• Vancouver

  Pandey RP, Nascimento MS, Franco CH, Bortoluci K, Silva MN da, Zingales B, Gibald D, Barrios LC, Vieira JL, Cariste LM, Vasconcelos JR, Moraes CB, Freitas Junior LH, Kalil Filho JE, Alcântara L, Cunha Neto E. Drug repurposing in chagas disease: chloroquine potentiates benznidazole activity against Trypanosoma cruzi In vitro and in vivo [Internet]. Antimicrobial Agents and Chemotherapy. 2022 ; 66( 11): 1-17.[citado 2026 abr. 16 ] Available from: https://doi.org/10.1128/aac.00284-22

Últimas obras dos mesmos autores vinculados com a USP cadastradas na BDPI:

• Trypanosoma cruzi benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease
• Modulation of class II MHC expression in human cells infected with Trypanosoma cruzi
• Designing and exploring active N '-[(5-nitrofuran-2-yl) methylene] substituted hydrazides against three Trypanosoma cruzi strains more prevalent in Chagas disease patients
• Evidence for T Cell help in the IgG response against tandemly repetitive Trypanosoma cruzi B13 protein in chronic Chagas disease patients
• STING signaling drives production of Innate Cytokines, generation of CD8+ T cells and enhanced protection against Trypanosoma cruzi infection
• Optomization of two-dimensional electrophoresis for human cardic tissues: Valve and myocardium
• Novel HIV multiepitopic and multiallelic vaccine formulations elicit strong CD4+ and CD8+ immune responses in BALB/c and HLA lcass II trangenic mice
• Identification of CD4+Tcell epitopes in HIV-1 protease: Recognition of protease inhibitor induced mutations
• Polymorphisms in genes affecting interferon-gamma production and Th1 T Cell differentiation are associated with progression to chagas disease cardiomyopathy (vol 11, 1386, 2020)
• HIV CD4 based vaccine increases CD8 cell responses andconfers protection against challenge with recombinant vaccinia enconding HIV gag-pol proteins